Conatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)
A2331
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameConatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionConatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) with a Kd of 1 nM and 0.8 nM for the long form and the short form of DR5, respectively. Conatumumab induces apoptosis via caspase activation. MW : 144.96 KD.
- Storage Instruction-20°C
- UNSPSC12352203